Manuel Durán Martínez

Dr. Manuel Durán Martínez

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
GWGo Wakabayashi
Go Wakabayashi
DCDaniel Cherqui
Daniel Cherqui
DGDavid A. Geller
David A. Geller
MHMohammed Abu Hilal
Mohammed Abu Hilal
GBGiammauro Berardi
Giammauro Berardi
MYMasakazu Yamamoto
Masakazu Yamamoto

15 November 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
NGNaoto Gotohda
Naoto Gotohda
DCDaniel Cherqui
Daniel Cherqui
DGDavid A. Geller
David A. Geller
MHMohammed Abu Hilal
Mohammed Abu Hilal
GBGiammauro Berardi
Giammauro Berardi
GWGo Wakabayashi
Go Wakabayashi

6 December 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
MMMamoru Morimoto
Mamoru Morimoto
KMKazuteru Monden
Kazuteru Monden
TWTaiga Wakabayashi
Taiga Wakabayashi
NGNaoto Gotohda
Naoto Gotohda
YAYuta Abe
Yuta Abe
GWGo Wakabayashi
Go Wakabayashi

19 August 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
MMManuel Durán Martínez
Manuel Durán Martínez
JSJosé Silvestre
José Silvestre
JHJara Hernández
Jara Hernández
JBJavier Briceño
Javier Briceño
AMAlberto Martínez‐Isla
Alberto Martínez‐Isla
DMDavid Martínez‐Cecilia
David Martínez‐Cecilia

17 January 2023 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
PDF file
JRJesús David Rubio-López
Jesús David Rubio-López
MMManuel Durán Martínez
Manuel Durán Martínez
AMAndrea Moreno-Blázquez
Andrea Moreno-Blázquez
LRLidia Rodríguez-Ortiz
Lidia Rodríguez-Ortiz
BRBlanca Rufián-Andújar
Blanca Rufián-Andújar
AAAlvaro Arjona-Sanchez
Alvaro Arjona-Sanchez
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) causes considerable hemodynamic, respiratory, and metabolic changes during the perioperative period. Objectives: To evaluate metabolic changes associated with this procedure. Understanding perioperative factors and their association with morbidity may improve the perioperative management of patients undergoing this treatment. Methods: A retrospective review of a prospectively maintained database was performed. All consecutive unselected patients who underwent CRS plus HIPEC between January 2018 and December 2020 (n = 219) were included. Results: The mean age was 58 ± 11.7 years and 167 (76.3%) were female. The most frequent histology diagnosis was serous ovarian carcinoma 49.3% (n = 108) and colon carcinoma 36.1% (n = 79). Mean peritoneal cancer index was 14.07 ± 10.47. There were significant variations in pH, lactic acid, sodium, potassium, glycemia, bicarbonate, excess bases, and temperature (p < 0.05) between the pre-HIPEC and post-HIPEC periods. The closed HIPEC technique resulted in higher levels of temperature than the open technique (p < 0.05). Age, potassium level post-HIPEC potassium level, and pre-HIPEC glycemia were identified as prognostic factors for morbidity in multivariate analysis. Conclusion: The administration of HIPEC after CRS causes significant changes in internal homeostasis. Although the closed technique causes a greater increase in temperature, it is not related to higher morbidity rates. The patient’s age, post-HIPEC potassium level, and pre-HIPEC glycemia are predictive factors for morbidity.

24 July 2018 in Cirugía Española
Verified
Journal Article
Closed access
JSJuan Manuel Sánchez-Hidalgo
Juan Manuel Sánchez-Hidalgo
SRSebastián Rufián-Peña
Sebastián Rufián-Peña
MMManuel Durán Martínez
Manuel Durán Martínez
AAAlvaro Arjona-Sanchez
Alvaro Arjona-Sanchez
ISInmaculada Salcedo-Leal
Inmaculada Salcedo-Leal
JBJavier Briceño-Delgado
Javier Briceño-Delgado